IFOM   Report issue

Academic/Hospital Phase 2
Founded: Milan Italy

Organization Overview

First Clinical Trial
2018
NCT03589014
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

IFOM (Istituto FIRC di Oncologia Molecolare) | IFOM, The FIRC Institute of Molecular Oncology